Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03186508 · ClinicalTrials.gov registry record · NA

Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal

A NA study of Obesity and Sleep, sponsored by Temple University.

Completed
Registry status
NA
Development phase
149
Enrollment target
1
Study location

NCT03186508: Completed NA study of Obesity and Sleep, sponsored by Temple University.

NCT03186508 is a NA study of Obesity and Sleep that has completed, run by Temple University. The registered enrollment target is 149 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03186508, a NA study of Obesity and Sleep, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
149 participants
Enrollment target
1
Study location

Study Summary

Enhancing children's sleep may be a novel approach for prevention of obesity and cardiovascular (CV) disturbance. Observational studies with children demonstrate that short sleep increases risk of obesity and other CV risk factors. Randomized controlled trials with children 8-11 years old demonstrate that enhancing sleep duration leads to positive changes in eating and activity behaviors and weight status, particularly for children who enhance their sleep the most. Enhancing sleep may be particularly important for racial minority children and those from lower socioeconomic backgrounds given their increased risk for short sleep, obesity and CV risk factors. In this study two active obesity preventive interventions will be evaluated: a) enhancing sleep alone (Optimize Sleep \[OS\]), and b) enhancing sleep along with eating and activity behaviors that have demonstrated efficacy for obesity prevention and are implicated in self-regulatory pathways related to sleep (i.e., energy dense snack foods and beverages, TV viewing, and physical activity) (OS-Plus). Two hundred four children 6-11 years old who are primarily African American/black, primarily from low socioeconomic backgrounds, and who sleep \< 9.5 hours/night into a 12-month study will be enrolled. Children will be randomly assigned to either OS or OS-Plus. Over the 6-month treatment phase, all children will attend an 8-session treatment; monthly phone contacts will occur during maintenance (6-12 months). Primary aim is to determine the efficacy of OS-Plus relative to OS on change in body mass index z-score (BMIz) at end of treatment. Secondary aims will assess efficacy of OS-Plus relative to OS on additional cardiometabolic risk factors, eating and activity behaviors. Exploratory aims will assess maintenance of effects at 12 months.

Primary Outcome

change in body mass index z-score (accounting for child age and sex)

Conditions Studied

Interventions

  • BEHAVIORAL Optimize Sleep (OS)
  • BEHAVIORAL Optimize Sleep-Plus (OS-Plus)

Study Locations (1)

Pennsylvania

  • Temple University - Philadelphia

Trial Details

FieldValue
Enrollment Target 149 participants
Start Date 2018-02-28
Est. Completion 2023-09-19
Phase NA
Temple University

163 total trials

What the finished NCT03186508 record still lists

NCT03186508 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Optimize Sleep (OS) is the first listed.

NCT03186508 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03186508 about?

NCT03186508 is a clinical study titled "Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal". Enhancing children's sleep may be a novel approach for prevention of obesity and cardiovascular (CV) disturbance. Observational studies with children demonstrate that short sleep increases risk of obesity and other CV risk factors. Randomized controlled trials with children 8-11 years old demonstrat...

What is the current status of trial NCT03186508?

This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2018-02-28. Estimated completion is 2023-09-19.

What conditions does trial NCT03186508 study?

This clinical trial studies the following conditions: Obesity, Sleep.

What interventions are being tested in trial NCT03186508?

The interventions under investigation include: Optimize Sleep (OS) (BEHAVIORAL), Optimize Sleep-Plus (OS-Plus) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03186508?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03186508 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03186508's enrollment target sits among peer trials

149 387th of 1053 higher than 666 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04188535 · 149 participants · NA

    Serial MRI Scans During Radiation Therapy

  • NCT05828511 · 149 participants · Phase 1

    A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03186508, the US trial registry maintained by the National Library of Medicine. NCT03186508 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.